PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PanGenomic Health, Inc. has announced an anticipated delay in filing its 2023 financial statements, with a new expected filing date set on or before June 28, 2024, due to payment delays to its auditors. The British Columbia Securities Commission has issued a management cease trade order that restricts company executives from trading securities, but does not hinder shareholder trading. The company is following NP 12-203 guidelines and will continue to provide bi-weekly status updates.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.